Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,572 | -29,524 | -13,886 | -7,665 | -6,574 |
| Depreciation Amortization | 582 | 561 | 3,417 | 1,334 | 825 |
| Other Working Capital | -28 | 283 | 2,132 | 1,770 | 850 |
| Other Operating Activity | 33,688 | 27,857 | 5,569 | 2,686 | 3,366 |
| Operating Cash Flow | $-2,330 | $-823 | $-2,769 | $-1,874 | $-1,533 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -49 | -13 | -308 | -241 | -197 |
| Common Stock Issued | 280 | 280 | 3,147 | 2,128 | 1,730 |
| Other Financing Activity | 2,723 | 608 | 0 | 0 | 0 |
| Financing Cash Flow | $2,954 | $874 | $2,839 | $1,888 | $1,533 |
| Beginning Cash Position | 70 | 70 | N/A | N/A | N/A |
| End Cash Position | 694 | 121 | 70 | 13 | N/A |
| Net Cash Flow | $624 | $51 | $70 | $13 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,330 | -823 | -2,769 | -1,874 | -1,533 |
| Free Cash Flow | -2,330 | -823 | -2,769 | -1,874 | -1,533 |